Nanobiotix Engages in Premier Investment Conference

Nanobiotix (NBTX) has released an update.

Nanobiotix, a pioneering biotech firm in cancer treatment, will present at the H.C. Wainwright 26th Annual Global Investment Conference, with a live webcast from New York. The company’s management will engage in a fireside chat, showcasing their innovative, physics-based therapies which have the potential to improve treatment for millions of patients.

For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.